These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20980145)

  • 1. Enhanced production of ansamitocin P-3 by addition of isobutanol in fermentation of Actinosynnema pretiosum.
    Lin J; Bai L; Deng Z; Zhong JJ
    Bioresour Technol; 2011 Jan; 102(2):1863-8. PubMed ID: 20980145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced production of ansamitocin P-3 by addition of Mg2+ in fermentation of Actinosynnema pretiosum.
    Jia Y; Zhong JJ
    Bioresour Technol; 2011 Nov; 102(21):10147-50. PubMed ID: 21907573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asm8, a specific LAL-type activator of 3-amino-5-hydroxybenzoate biosynthesis in ansamitocin production.
    Pan W; Kang Q; Wang L; Bai L; Deng Z
    Sci China Life Sci; 2013 Jul; 56(7):601-8. PubMed ID: 23832249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic studies on anti-tumor agent ansamitocin P-3 producer Actinosynnema pretiosum in response to ammonium and isobutanol.
    Lin J; Zhong JJ
    Bioprocess Biosyst Eng; 2017 Jul; 40(7):1133-1139. PubMed ID: 28382459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the Methylmalonyl-CoA Metabolic Pathway on Ansamitocin Production in Actinosynnema pretiosum.
    Zhao M; Fan Y; Wei L; Hu F; Hua Q
    Appl Biochem Biotechnol; 2017 Mar; 181(3):1167-1178. PubMed ID: 27787765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of ansamitocin P-3 production by Actinosynnema mirum with fructose as the sole carbon source.
    Li T; Fan Y; Nambou K; Hu F; Imanaka T; Wei L; Hua Q
    Appl Biochem Biotechnol; 2015 Mar; 175(6):2845-56. PubMed ID: 25564203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The post-polyketide synthase modification steps in the biosynthesis of the antitumor agent ansamitocin by Actinosynnema pretiosum.
    Spiteller P; Bai L; Shang G; Carroll BJ; Yu TW; Floss HG
    J Am Chem Soc; 2003 Nov; 125(47):14236-7. PubMed ID: 14624546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational approach to improve ansamitocin P-3 production by integrating pathway engineering and substrate feeding in Actinosynnema pretiosum.
    Du ZQ; Zhong JJ
    Biotechnol Bioeng; 2018 Oct; 115(10):2456-2466. PubMed ID: 29940067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic change and pathway profiling reveal enhanced ansamitocin P-3 production in Actinosynnema pretiosum with low organic nitrogen availability in culture medium.
    Liu T; Yang L; Chen J; Hu F; Wei LJ; Hua Q
    Appl Microbiol Biotechnol; 2020 Apr; 104(8):3555-3568. PubMed ID: 32114676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process optimization with alternative carbon sources and modulation of secondary metabolism for enhanced ansamitocin P-3 production in Actinosynnema pretiosum.
    Fan Y; Gao Y; Zhou J; Wei L; Chen J; Hua Q
    J Biotechnol; 2014 Dec; 192 Pt A():1-10. PubMed ID: 25456055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of ansamitocin P-3 production in Actinosynnema pretiosum by a synergistic effect of glycerol and glucose.
    Gao Y; Fan Y; Nambou K; Wei L; Liu Z; Imanaka T; Hua Q
    J Ind Microbiol Biotechnol; 2014 Jan; 41(1):143-52. PubMed ID: 24174216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of traditional mutation and metabolic engineering to enhance ansamitocin P-3 production in Actinosynnema pretiosum.
    Du ZQ; Zhang Y; Qian ZG; Xiao H; Zhong JJ
    Biotechnol Bioeng; 2017 Dec; 114(12):2794-2806. PubMed ID: 28782796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparative isolation and purification of anti-tumor agent ansamitocin P-3 from fermentation broth of Actinosynnema pretiosum using high-performance counter-current chromatography.
    Yao Y; Cheng Z; Ye H; Xie Y; He J; Tang M; Shen T; Wang J; Zhou Y; Lu Z; Luo F; Chen L; Yu L; Yang JL; Peng A; Wei Y
    J Sep Sci; 2010 May; 33(9):1331-7. PubMed ID: 20235129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the cryptic stereochemistry of the first PKS chain-extension step in ansamitocin biosynthesis by Actinosynnema pretiosum.
    Kubota T; Brünjes M; Frenzel T; Xu J; Kirschning A; Floss HG
    Chembiochem; 2006 Aug; 7(8):1221-5. PubMed ID: 16927319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics analysis of Actinosynnema pretiosum with improved AP-3 production by enhancing UDP-glucose biosynthesis.
    Liu T; Jin Z; Wang Z; Chen J; Wei LJ; Hua Q
    J Biosci Bioeng; 2020 Jul; 130(1):36-47. PubMed ID: 32179024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of the Delta(10,12)-Delta(11,13) double bond migration during ansamitocin biosynthesis in Actinosynnema pretiosum.
    Taft F; Brünjes M; Knobloch T; Floss HG; Kirschning A
    J Am Chem Soc; 2009 Mar; 131(11):3812-3. PubMed ID: 19292483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational biosynthesis of ansamitocin antibiotics: a diversity-oriented approach to exploit biosynthetic flexibility.
    Knobloch T; Harmrolfs K; Taft F; Thomaszewski B; Sasse F; Kirschning A
    Chembiochem; 2011 Mar; 12(4):540-7. PubMed ID: 22238146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete Genome Sequence of Actinosynnema pretiosum X47, An Industrial Strain that Produces the Antibiotic Ansamitocin AP-3.
    Zhong C; Zong G; Qian S; Liu M; Fu J; Zhang P; Li J; Cao G
    Curr Microbiol; 2019 Aug; 76(8):954-958. PubMed ID: 29858620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new antitumour ansamitocin from Actinosynnema pretiosum.
    Wei GZ; Bai LQ; Yang T; Ma J; Zeng Y; Shen YM; Zhao PJ
    Nat Prod Res; 2010 Jul; 24(12):1146-50. PubMed ID: 20582809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased yield of AP-3 by inactivation of asm25 in Actinosynnema pretiosum ssp. auranticum ATCC 31565.
    Cheng H; Xiong G; Li Y; Zhu J; Xiong X; Wang Q; Zhang L; Dong H; Zhu C; Liu G; Chen H
    PLoS One; 2022; 17(3):e0265517. PubMed ID: 35316825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.